Allison Singier
Epidemiology Of Health Products, 143-147 Boulevard Anatole France
Saint-denis-de-palin, 93285, France
Saint-denis-de-palin, 93285, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Correction: Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent Endometrial Cancer: A Nationwide Cohort Study in France.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: May 05, 2026
Use, survival, and adverse events of dostarlimab monotherapy in advanced or recurrent endometrial cancer: a nationwide cohort study in France.
Journal: The oncologist
Published: April 24, 2026
Overall survival according to COVID-19 mRNA vaccination co-exposure in patients treated with PD-(L)1 inhibitors: a French real-world cohort study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 03, 2026
Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent dMMR Endometrial Cancer: A Nationwide Cohort Study in France.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: February 06, 2026
Angiogenesis Inhibitors and Arterial Dissection or Aneurysm in Patients With Metastatic Colorectal Cancer.
Journal: JAMA network open
Published: December 04, 2025
Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database.
Journal: Drug safety
Published: June 23, 2025
Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database.
Journal: Drug safety
Published: April 22, 2025
Validation of JEM Soignances Job-Exposure Matrix Through Comparison with Self-Reported Exposures Among Healthcare Workers in CONSTANCES.
Journal: Journal of occupational rehabilitation
Published: March 12, 2025
Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database.
Journal: Drug safety
Published: February 17, 2025
Development and validation of a French job-exposure matrix for healthcare workers: JEM Soignances.
Journal: Scandinavian journal of work, environment & health
Published: October 29, 2024
PCSK9 inhibitors patterns of use in France from nationwide repeated cross-sectional and cohort studies.
Journal: Scientific reports
Published: August 30, 2024
Suicidal behaviour and CFTR modulators: A case series and WHO database disproportionality analysis.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: February 21, 2024
Last Updated: 09/26/2026